Evidence map›Paper›PMID 32929120›Full record

ArticleScientific reports2020

UQCRH downregulation promotes Warburg effect in renal cell carcinoma cells.

Yanting Luo, Louise Medina Bengtsson, Xuechun Wang, Tianhe Huang, Guoqiang Liu, Sean Murphy, Caiqin Wang, John Koren, Zachary Schafer, Xin Lu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Biomedicines · 2023
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Frontiers in endocrinology · 2022
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yanting Luo *Department of Biological Sciences, Boler-Parseghian Center for Rare and Neglected Diseases, University of Notre Dame, 193 Galvin Life Sciences Center, Notre Dame, IN, 46556, USA.
Louise Medina Bengtsson *Department of Biological Sciences, Boler-Parseghian Center for Rare and Neglected Diseases, University of Notre Dame, 193 Galvin Life Sciences Center, Notre Dame, IN, 46556, USA.
Xuechun Wang *Department of Biological Sciences, Boler-Parseghian Center for Rare and Neglected Diseases, University of Notre Dame, 193 Galvin Life Sciences Center, Notre Dame, IN, 46556, USA.
Tianhe HuangDepartment of Biological Sciences, Boler-Parseghian Center for Rare and Neglected Diseases, University of Notre Dame, 193 Galvin Life Sciences Center, Notre Dame, IN, 46556, USA.
Guoqiang LiuDepartment of Biological Sciences, Boler-Parseghian Center for Rare and Neglected Diseases, University of Notre Dame, 193 Galvin Life Sciences Center, Notre Dame, IN, 46556, USA.
Sean MurphyDepartment of Biological Sciences, Boler-Parseghian Center for Rare and Neglected Diseases, University of Notre Dame, 193 Galvin Life Sciences Center, Notre Dame, IN, 46556, USA.
Caiqin WangDepartment of Biological Sciences, Boler-Parseghian Center for Rare and Neglected Diseases, University of Notre Dame, 193 Galvin Life Sciences Center, Notre Dame, IN, 46556, USA.
John KorenDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN, 46556, USA.
Zachary SchaferDepartment of Biological Sciences, Boler-Parseghian Center for Rare and Neglected Diseases, University of Notre Dame, 193 Galvin Life Sciences Center, Notre Dame, IN, 46556, USA.
Xin LuDepartment of Biological Sciences, Boler-Parseghian Center for Rare and Neglected Diseases, University of Notre Dame, 193 Galvin Life Sciences Center, Notre Dame, IN, 46556, USA. xlu@nd.edu.
University of Notre Dame · USIndiana University – Purdue University Indianapolis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ubiquinol-cytochrome c reductase hinge protein (UQCRH) is the hinge protein for the multi-subunit complex III of the mitochondrial electron transport chain and is involved in the electron transfer reaction between cytochrome c1 and c. Recent genome-wide transcriptomic and epigenomic profiling of clear cell renal cell carcinoma (ccRCC) by The Cancer Genome Atlas (TCGA) identified UQCRH as the top-ranked gene showing inverse correlation between DNA hypermethylation and mRNA downregulation. The function and underlying mechanism of UQCRH in the Warburg effect metabolism of ccRCC have not been characterized. Here, we verified the clinical association of low UQCRH expression and shorter survival of ccRCC patients through in silico analysis and identified KMRC2 as a highly relevant ccRCC cell line that displays hypermethylation-induced UQCRH extinction. Ectopic overexpression of UQCRH in KMRC2 restored mitochondrial membrane potential, increased oxygen consumption, and attenuated the Warburg effect at the cellular level. UQCRH overexpression in KMRC2 induced higher apoptosis and slowed down in vitro and in vivo tumor growth. UQCRH knockout by CRISPR/Cas9 had little impact on the metabolism and proliferation of 786O ccRCC cell line, suggesting the dispensable role of UQCRH in cells that have entered a Warburg-like state through other mechanisms. Together, our study suggests that loss of UQCRH expression by hypermethylation may promote kidney carcinogenesis through exacerbating the functional decline of mitochondria thus reinforcing the Warburg effect.

Indexed as

Warburg Effect, OncologicAnimalsApoptosisCarcinoma, Renal CellCell Line, TumorDNA MethylationDown-RegulationElectron Transport Complex IIIHumansKidney NeoplasmsMaleMiceElectron Transport Complex IIIUQCRH protein, human

Identifiers

PMID32929120
PMCPMC7490363
OpenAlexW3085963344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.